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Sialylation is a unique modification of glycans existing in different 
glycoproteins on cell surfaces, which significantly modulates many important 
physiological and pathological processes, such as anti-inflammatory and 
tumor metastasis. Despite tremendous efforts on the synthesis of this crucial 
glycan decoration using chemical and enzymatic methods, site-specific 
attachment of sialic acid moieties onto biologically important glycopeptides
or glycoproteins is still challenging. In the last two decades, converting 
glycosidases into their transfer mutants has become a fascinating approach in 
the synthesis of glycoconjugates. In this work, a bacterial α2,6-sialidase 
(MvNA) from Micromonospora viridifaciens was selected as candidate for 
efficient transfer of sialic acid in a regio- and stereo-controlled manner due to 
its inherent trans-sialylation activity. First, wild-type MvNA was cloned and 
overexpressed in E. coli. Two types of sialidase mutants with mutation site at 
the nucleophile (Y370) and the general acid/base (D92) residues were then 
created by site-directed mutagenesis and successfully expressed. In the 
preliminary activity tests, the wild-type MvNA showed strong hydrolytic 
activity towards a natural sialylated complex-type N-glycopeptide, while 
terminal sialic acids from the same glycopeptide can’t be removed by created 
MvNA mutants, including Y370A, Y370G and D92A. The potential trans-
sialylation activities of those sialidase mutants will be systematically tested 
using various synthetic activated substrate donors, such as sialyl fluorides 
and nitrophenyl sialosides. We are also aiming to create sialidase mutants 
derived from other types of sialidases with distinct specificities, e.g. α2,3 and 
α2,8-linkages. The potential sialidase transfer mutants could provide a new 
avenue to access the structurally well-defined sialylated glycopeptides and 
glycoproteins for sialylation bio-function study and therapeutic applications. 
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Chemical methods
1. Need of protection and deprotection steps.
2. Hard to control stereo/regio-chemistry.
Enzymatic methods
1. Mammalian sialyltransferases are mostly membrane proteins that are
not easy to express in E. coli system.
2. Donor substrate sources are very specific and are usually expensive
(sugar nucleotides or sugar phosphate).
3. Low to moderate yields obtained usually for protein sialylation (<50%).
Limitations of Current Synthesis Methods
Experimental Design
Glycosynthase is a glycosidase mutant where the nucleophile residue is 
eliminated. An activated donor substrate mimics the enzyme-substrate 
complex.  Shown above is reaction scheme for a retaining β-glycosynthase 
mutant3.
Glycoligase is a glycosidase mutant where the general acid/base residue is 
eliminated. Donor used have same anomeric configuration as substrate used 
in wild type enzyme. Shown above is reaction scheme for an inverting α-
glycoligase mutant3.
Cloning Expression and purification Hydrolytic activity test
Genomic DNA of MvNA (1944 bp) was 
amplified using Phusion hot start II DNA 
polymerase. DNA obtained was digested 
and cloned into digested pET28a vector 
(5369 bp). Obtained PCR product was 
amplified with DH5α competent cell. DNA 
extracted was loaded on DNA gel for 
characterization.
Successfully cloned 
plasmids were transformed 
into BL21 E. Coli competent 
cells for expression. Crude 
cellular protein suspension 
was then purified with 
HisTrap column. The 
purified protein sample 
was loaded onto protein 
gel and check for identity.
Site-directed mutagenesis
Nucleophilic active site (Y370) and general 
acid/base active site (D92) were mutated 
through site-directed mutagenesis. 
Mutated DNA plasmids were sent for 
sequencing and the correct plasmids were 
amplified with DH5α competent cell. The 
mutants were then expressed and purified. 
Sialyl glycopeptide (SGP) was used as substrate 
for hydrolytic activity test for WT MvNA through 
a 1:500 molecular ratio reaction. Hydrolytic 
activity was monitored through HPLC with 0-5% 
acetonitrile gradient.  
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MvNA WT MvNA Sialosynthase
MvNA is a sialidase with three active sites, Y370, D92, and E260.
Shown above is the mechanism of hydrolysis for MvNA WT4.
SGP was used to test hydrolytic 
activity of WT, Y370A, and Y370G 
mutants and mass spectra was 
obtained using LC-ESI-MS. 
Above shows plasmid were digested and 
linearized loaded in lane 3,4, and 10 were 
around 7 kbp in length compared to the 
ladder where others appears to be at 
around 5 kbp in length. 
A
B
Above shows A) SGP standard, B) MvNA WT 
hydrolysis reaction mixture. 
Shown above is the transition state proposed for sialosynthase
Y370G mutant using 2-fluorophenyl as donor substrate5.
Above shows the band to be between 50 
and 75 kD where MvNA WT has M.W. of 68 
kD.
On left shows mass spectra of 
A) SGP standard, B) WT 
reaction, C) Y370 A mutant 
reaction, and D) Y370G mutant 
reaction. No specific hydrolytic 
activity was found in the 
mutants generated. 
Structure of N-acetylneuraminic 
acid, a major sialic acid residue 
produced in human 
glycoconjugates.
Sialylation in Fc region of antibodies 
has shown to enhance anti-
inflammatory properties1.
Increased terminal sialylation in 
therapeutic glycoproteins (e.g. 








1. Transfer activity test on the sialosynthase using synthetic sugar 
fluorides and sialosides with different leaving groups. 
Illustrations above shows sialosides synthesized by Yuanwei Dai 
with α and β-configurations
2. Hydrolytic activity and transfer activity test on D92A mutant.
3. Explore α2,3 and α2,8 sialidases.
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